Chapter 8: Problem 3
Succinylcholine is a fast-acting, short-duration muscle relaxant that is used when a tube is inserted into a patient's trachea or when a bronchoscope is used to examine the trachea and bronchi for signs of cancer. Within seconds of the administration of succinylcholine, the patient experiences muscle paralysis and is placed on a respirator while the examination proceeds. Succinylcholine is a competitive inhibitor of acetylcholinesterase, a nervous system enzyme, and this inhibition causes paralysis. However, succinylcholine is hydrolyzed by blood-serum cholinesterase, which shows broader substrate specificity than does the nervous system enzyme. Paralysis lasts until the succinylcholine is hydrolyzed by the serum cholinesterase, usually several minutes later. (a) As a safety measure, serum cholinesterase is measured before the examination takes place. Explain why this measurement is good idea. (b) What would happen to the patient if the serum cholinesterase activity were only 10 units of activity per liter rather than the normal activity of about 80 units? (c) Some patients have a mutant form of the serum cholinesterase that displays a \(K_{M}\) of \(10 \mathrm{mM},\) rather than the normal 1.4 mM. What will be the effect of this mutation on the patient?
Short Answer
Step by step solution
Key Concepts
These are the key concepts you need to understand to accurately answer the question.